ES2174039T3 - Utilizacion de al menos un peptido que contiene el tripeptido lys-dpro-arg para la preparacion de un medicamento para el tratamiento de la inflamacion. - Google Patents

Utilizacion de al menos un peptido que contiene el tripeptido lys-dpro-arg para la preparacion de un medicamento para el tratamiento de la inflamacion.

Info

Publication number
ES2174039T3
ES2174039T3 ES96401784T ES96401784T ES2174039T3 ES 2174039 T3 ES2174039 T3 ES 2174039T3 ES 96401784 T ES96401784 T ES 96401784T ES 96401784 T ES96401784 T ES 96401784T ES 2174039 T3 ES2174039 T3 ES 2174039T3
Authority
ES
Spain
Prior art keywords
preparation
peptide containing
medicinal product
inflammation
dpro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96401784T
Other languages
English (en)
Inventor
Yann Mahe
Bruno Buan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Application granted granted Critical
Publication of ES2174039T3 publication Critical patent/ES2174039T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0815—Tripeptides with the first amino acid being basic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/70—Biological properties of the composition as a whole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Molecular Biology (AREA)
  • Birds (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)

Abstract

LA INVENCION SE REFIERE A LA UTILIZACION COMO PRINCIPIO ACTIVO, EN UN MEDIO FISIOLOGICAMENTE ACEPTABLE, EN UNA COMPOSICION COSMETICA O PARA LA PREPARACION DE UN MEDICAMENTO, DE UNA CANTIDAD EFICAZ DE AL MENOS UN PEPTIDO QUE CONTIENE EL TRIPEPTIDO LISINA-PROLINA-VALINA, O DE CUALQUIER EQUIVALENTE BIOLOGICO FUNCIONAL EN EL QUE EL RESIDUO PROLINA ESTA LA FORMA DE SU ISOMERO OPTICO DEXTROGIRO, DESTINADA A TRATAR LA INFLAMACION. LA INVENCION SE REFIERE TAMBIEN A UN PROCEDIMIENTO DE TRATAMIENTO COSMETICO.
ES96401784T 1995-09-19 1996-08-13 Utilizacion de al menos un peptido que contiene el tripeptido lys-dpro-arg para la preparacion de un medicamento para el tratamiento de la inflamacion. Expired - Lifetime ES2174039T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9510977A FR2738746B1 (fr) 1995-09-19 1995-09-19 Utilisation d'au moins un peptide dans une composition cosmetique ou pour la preparation d'un medicament

Publications (1)

Publication Number Publication Date
ES2174039T3 true ES2174039T3 (es) 2002-11-01

Family

ID=9482701

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96401784T Expired - Lifetime ES2174039T3 (es) 1995-09-19 1996-08-13 Utilizacion de al menos un peptido que contiene el tripeptido lys-dpro-arg para la preparacion de un medicamento para el tratamiento de la inflamacion.

Country Status (12)

Country Link
US (2) US20050026845A1 (es)
EP (1) EP0764444B1 (es)
JP (1) JP2831979B2 (es)
AR (1) AR003589A1 (es)
CA (1) CA2185932C (es)
DE (1) DE69619753T2 (es)
ES (1) ES2174039T3 (es)
FR (1) FR2738746B1 (es)
MX (1) MX9710252A (es)
PL (1) PL186767B1 (es)
RU (1) RU2180590C2 (es)
WO (1) WO1997010838A1 (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2784028B1 (fr) * 1998-10-01 2003-02-07 Oreal Utilisation d'un peptide prevenant les reactions d'intolerance de la peau, notamment dans des compositions cosmetiques
US6803044B1 (en) 1999-03-24 2004-10-12 Zengen, Inc. Antimicrobial and anti-inflammatory peptides for use in human immunodeficiency virus
US6887846B2 (en) 1999-03-24 2005-05-03 Zengen, Inc. Antimicrobial amino acid sequences derived from alpha-melanocyte-stimulating hormone
US7402559B2 (en) 1999-03-24 2008-07-22 Msh Pharma, Incorporated Composition and method of treatment for urogenital conditions
US6800291B1 (en) 1999-03-24 2004-10-05 Zengen, Inc. Uro-genital condition treatment system
PT1092427E (pt) * 1999-10-04 2007-08-06 Oreal Utilização de um péptido para prevenir as reacções de intolerância da pele em especial nas composições cosméticas
US6780838B2 (en) 2001-01-29 2004-08-24 Zengen, Inc. Compounds for treating fungal pathologies of the oral cavity
US6894028B2 (en) 2001-04-06 2005-05-17 Zengen, Inc. Use of KPV tripeptide for dermatological disorders
FR2826263B1 (fr) * 2001-06-26 2005-02-25 Oreal Composition cosmetique ou dermatologique comprenant une association entre un compose inhibiteur de l'elastase de la famille des n-acylaminoamides et au moins un compose anti-inflammatoire
FR2826580B1 (fr) * 2001-06-29 2005-09-30 Oreal Utilisation du tripeptide lys-pro-val (kpv) pour favoriser le renouvellement epidermique et la micro-cicatrisation cutanee superficielle et/ou ameliorer l'aspect esthetique des plaies et cicatrices
FR2826581B1 (fr) * 2001-06-29 2005-10-07 Oreal Utilisation du tripeptide lys-pro-val (kpv) dans le traitement des melanomes
FR2827170B1 (fr) * 2001-07-13 2004-07-16 Soc Extraction Principes Actif Utilisation de peptides pour augmenter l'adhesion cellulaire
US7115574B2 (en) 2001-12-10 2006-10-03 Zengen, Inc. System and method for support legacy operating system booting in a legacy-free system
US6939846B2 (en) 2001-12-17 2005-09-06 Zengen, Inc. Use of a polypeptide for treatment of pruritis in animals
FR2846883B1 (fr) * 2002-11-08 2004-12-24 Vincience Composition cosmetique comprenant, comme ingredient actif, au moins un peptide et utilisation de ce peptide
AU2003292326A1 (en) 2002-11-08 2004-06-03 Societe D'extraction Des Principes Actifs (Vincience) Cosmetic or pharmaceutical composition comprising peptides with the sequence arg-gly-ser
US9387235B2 (en) 2004-06-14 2016-07-12 Basf Beauty Care Solutions France S.A.S. Cosmetic preparations containing PTH fragments
US7300649B2 (en) 2005-02-11 2007-11-27 Genepharm, Inc. Cosmetic and cosmeceutical compositions for restoration of skin barrier function
EP3495381A1 (en) * 2009-12-08 2019-06-12 AMSilk GmbH Silk protein coatings
WO2014159798A1 (en) 2013-03-13 2014-10-02 Avery Dennison Corporation Improving adhesive properties
MX368628B (es) * 2013-09-23 2019-10-08 Dr August Wolff Gmbh & Co Kg Arzneimittel Tripeptidos antiinflamatorios.
KR102208853B1 (ko) * 2018-05-08 2021-01-28 오션펩 주식회사 주름개선 효능을 갖는 펩티드

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5028592A (en) * 1986-08-08 1991-07-02 Lipton James M Antipyretic and anti-inflammatory peptides
US5157023A (en) * 1984-08-21 1992-10-20 Lipton James M Antipyretic and anti-inflammatory lys pro val compositions and method of use
US4878744A (en) * 1985-12-30 1989-11-07 Capitol Records, Inc. Three dimensional reflex lens systems
WO1988000833A2 (en) * 1986-08-08 1988-02-11 Board Of Regents, The University Of Texas System Antipyretic and anti-inflammatory peptides
CA1340186C (en) * 1988-03-28 1998-12-15 British Technology Group Limited Peptides
GB8807427D0 (en) * 1988-03-28 1988-05-05 National Biological Standards Board Peptides
FR2784028B1 (fr) * 1998-10-01 2003-02-07 Oreal Utilisation d'un peptide prevenant les reactions d'intolerance de la peau, notamment dans des compositions cosmetiques

Also Published As

Publication number Publication date
US20050026845A1 (en) 2005-02-03
US20080038208A1 (en) 2008-02-14
JP2831979B2 (ja) 1998-12-02
EP0764444A1 (fr) 1997-03-26
WO1997010838A1 (fr) 1997-03-27
DE69619753T2 (de) 2002-08-08
EP0764444B1 (fr) 2002-03-13
JPH09124502A (ja) 1997-05-13
RU2180590C2 (ru) 2002-03-20
CA2185932A1 (fr) 1997-03-20
PL186767B1 (pl) 2004-02-27
PL324485A1 (en) 1998-05-25
DE69619753D1 (de) 2002-04-18
AR003589A1 (es) 1998-08-05
CA2185932C (fr) 2003-11-11
MX9710252A (es) 1998-03-31
FR2738746A1 (fr) 1997-03-21
FR2738746B1 (fr) 1997-11-14

Similar Documents

Publication Publication Date Title
ES2174039T3 (es) Utilizacion de al menos un peptido que contiene el tripeptido lys-dpro-arg para la preparacion de un medicamento para el tratamiento de la inflamacion.
BRPI9908182B8 (pt) composições de proteína de matriz para cura de feridas
ES2102921T3 (es) Utilizacion de derivados de la hormona estimuladora de los melanocitos de tipo alfa para estimular el crecimiento de los cabellos.
AR005940A1 (es) Composicion cosmetica de fijacion y brillo en aerosol, y procedimiento
AR002023A1 (es) Utilizacion no terapeutica de por lo menos un antagonista del peptido derivado del gen de la calcitonina es decir un antagonista de cgrp , utilizacion de dicho antagonista para la preparacion de una composicion que contiene un medio dermatologicamente o farmaceuticamente aceptable, procedimiento de tratamiento cosmetico, y composicion topica que comprende dicho antagonista
BR0009830A (pt) Composições para cuidados com a pele contendo uma combinação de substâncias ativas para cuidados com a pele
AR016751A1 (es) Metodo para inhibir la liberacion del peptido beta-amiloide en una celula, composicion farmaceutica y compuestos utiles en dicho metodo
ES2145143T3 (es) Copolimeros elastomericos termoplasticos y composiciones que los contienen para el cuidado del cabello y de la piel.
BR9712491A (pt) Composições cosméticas
ES2177636T3 (es) Utilizacion del agua empobrecida en deuterio en la preparacion de cosmeticos.
ATE220918T1 (de) Matrixprotein enthaltende zusammensetzungen zur wundheilung
ES2159403T3 (es) Poliuretanos termoplasticos que contienen principios activos.
AR004326A1 (es) Utilizacion de al menos un antagonista de tnf-alfa, composicion cosmetica, farmaceutica o dermatologica que contiene dicho antagonista y procedimiento detratamiento cosmetico empleando dicho antagonista.
ES2113222T3 (es) Utilizacion de derivados de acido benzoico para estimular el proceso de renovacion epidermica y tratar la piel.
ES2196313T3 (es) Utilizacion de inhibidores de la actividad del acido retinoico para el tratamiento de pieles sensibles y/o los daños agudos inducidos por las radiaciones uv.
BR9915955A (pt) Composição cosmética para cuidado com a pele, processo cosmético para tratar uma pele envelhecida e uso de 4- cromanona
ES2192779T3 (es) Modificacion cristalina de 1-(2,6-difluorbencil)-1h-1,2,3-triazol-4-carboxamida y su uso como antiepileptico.
PA8525801A1 (es) Compuestos de pirazol, composiciones farmacéuticas, y métodos para modular y/o inhibir la actividad de erab/hadh2
AR003901A1 (es) Composicion para el tratamiento de las fibras queratinicas que comprende al menos un polimero fijante y al menos un compuesto de tipo ceramida yprocedimientos.
ES2191083T3 (es) Composicion para limpiar y/o desinfectar instrumentos para uso medico.
ES2159697T3 (es) Utilizacion de un antagonista de cgrp para tratar los liquenes y los pruritos y composicion obtenida.
ES2102284T3 (es) Composicion cosmetica que comprende una asociacion de ceramidas y su utilizacion.
AR017664A1 (es) Formulaciones farmaceuticas de liberacion sostenida que contienen inhibidores de la alfa-glucosidasa y su uso para la manufactura de un medicamento
DE50300126D1 (de) Coffein enthaltende Zusammensetzung als Hauptflegemittel
ES2110057T3 (es) Composicion medicinal que contiene tcf-ii.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 764444

Country of ref document: ES